nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.166	0.196	CbGbCtD
Methimazole—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.108	0.128	CbGbCtD
Methimazole—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0943	0.111	CbGbCtD
Methimazole—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0682	0.0806	CbGbCtD
Methimazole—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0572	0.0675	CbGbCtD
Methimazole—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0546	0.0645	CbGbCtD
Methimazole—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0463	0.0548	CbGbCtD
Methimazole—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0462	0.0545	CbGbCtD
Methimazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0358	0.0422	CbGbCtD
Methimazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0332	0.0393	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0311	0.0367	CbGbCtD
Methimazole—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0267	0.0315	CbGbCtD
Methimazole—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0245	0.0289	CbGbCtD
Methimazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0153	0.018	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.015	0.0177	CbGbCtD
Methimazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.014	0.0165	CbGbCtD
Methimazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00954	0.0113	CbGbCtD
Methimazole—Pigmentation disorder—Etoposide—peripheral nervous system neoplasm	0.00438	0.029	CcSEcCtD
Methimazole—Pigmentation disorder—Epirubicin—peripheral nervous system neoplasm	0.00245	0.0162	CcSEcCtD
Methimazole—Neuritis—Vincristine—peripheral nervous system neoplasm	0.00242	0.016	CcSEcCtD
Methimazole—Pigmentation disorder—Doxorubicin—peripheral nervous system neoplasm	0.00227	0.015	CcSEcCtD
Methimazole—Lymphadenopathy—Isotretinoin—peripheral nervous system neoplasm	0.0021	0.0139	CcSEcCtD
Methimazole—Lymphadenopathy—Tretinoin—peripheral nervous system neoplasm	0.0021	0.0139	CcSEcCtD
Methimazole—Ageusia—Cisplatin—peripheral nervous system neoplasm	0.00197	0.013	CcSEcCtD
Methimazole—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00189	0.0125	CcSEcCtD
Methimazole—Lymphadenopathy—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.0105	CcSEcCtD
Methimazole—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00138	0.00914	CcSEcCtD
Methimazole—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00138	0.00914	CcSEcCtD
Methimazole—Neuropathy peripheral—Topotecan—peripheral nervous system neoplasm	0.00136	0.00903	CcSEcCtD
Methimazole—Neuropathy peripheral—Tretinoin—peripheral nervous system neoplasm	0.00135	0.00896	CcSEcCtD
Methimazole—Neuropathy peripheral—Isotretinoin—peripheral nervous system neoplasm	0.00135	0.00896	CcSEcCtD
Methimazole—Neuropathy peripheral—Melphalan—peripheral nervous system neoplasm	0.00134	0.00885	CcSEcCtD
Methimazole—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00133	0.0088	CcSEcCtD
Methimazole—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00129	0.00853	CcSEcCtD
Methimazole—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00129	0.00853	CcSEcCtD
Methimazole—Hepatitis—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00821	CcSEcCtD
Methimazole—Hepatitis—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00821	CcSEcCtD
Methimazole—Hepatitis—Melphalan—peripheral nervous system neoplasm	0.00122	0.0081	CcSEcCtD
Methimazole—Alopecia—Topotecan—peripheral nervous system neoplasm	0.0011	0.00731	CcSEcCtD
Methimazole—Neuritis—Epirubicin—peripheral nervous system neoplasm	0.0011	0.00726	CcSEcCtD
Methimazole—Alopecia—Tretinoin—peripheral nervous system neoplasm	0.0011	0.00725	CcSEcCtD
Methimazole—Alopecia—Isotretinoin—peripheral nervous system neoplasm	0.0011	0.00725	CcSEcCtD
Methimazole—Alopecia—Melphalan—peripheral nervous system neoplasm	0.00108	0.00716	CcSEcCtD
Methimazole—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00105	0.00697	CcSEcCtD
Methimazole—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00693	CcSEcCtD
Methimazole—Neuropathy peripheral—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00679	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00672	CcSEcCtD
Methimazole—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00671	CcSEcCtD
Methimazole—Ageusia—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00669	CcSEcCtD
Methimazole—Neuropathy peripheral—Vincristine—peripheral nervous system neoplasm	0.000989	0.00654	CcSEcCtD
Methimazole—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.000977	0.00647	CcSEcCtD
Methimazole—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.000974	0.00645	CcSEcCtD
Methimazole—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.000954	0.00631	CcSEcCtD
Methimazole—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.00094	0.00622	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—peripheral nervous system neoplasm	0.000935	0.00619	CcSEcCtD
Methimazole—Myalgia—Topotecan—peripheral nervous system neoplasm	0.000926	0.00613	CcSEcCtD
Methimazole—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.000926	0.00613	CcSEcCtD
Methimazole—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.000919	0.00608	CcSEcCtD
Methimazole—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.000919	0.00608	CcSEcCtD
Methimazole—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.000919	0.00608	CcSEcCtD
Methimazole—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.000919	0.00608	CcSEcCtD
Methimazole—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000907	0.006	CcSEcCtD
Methimazole—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.000896	0.00593	CcSEcCtD
Methimazole—Oedema—Tretinoin—peripheral nervous system neoplasm	0.000881	0.00583	CcSEcCtD
Methimazole—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.000881	0.00583	CcSEcCtD
Methimazole—Neuropathy peripheral—Cisplatin—peripheral nervous system neoplasm	0.000874	0.00579	CcSEcCtD
Methimazole—Oedema—Melphalan—peripheral nervous system neoplasm	0.000869	0.00576	CcSEcCtD
Methimazole—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000869	0.00576	CcSEcCtD
Methimazole—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000862	0.00571	CcSEcCtD
Methimazole—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000862	0.00571	CcSEcCtD
Methimazole—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000851	0.00564	CcSEcCtD
Methimazole—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.00083	0.0055	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000809	0.00536	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000803	0.00531	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000803	0.00531	CcSEcCtD
Methimazole—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.000801	0.0053	CcSEcCtD
Methimazole—Alopecia—Vincristine—peripheral nervous system neoplasm	0.0008	0.0053	CcSEcCtD
Methimazole—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000797	0.00528	CcSEcCtD
Methimazole—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000796	0.00527	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000792	0.00524	CcSEcCtD
Methimazole—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000791	0.00524	CcSEcCtD
Methimazole—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000791	0.00524	CcSEcCtD
Methimazole—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00079	0.00523	CcSEcCtD
Methimazole—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000783	0.00518	CcSEcCtD
Methimazole—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000783	0.00518	CcSEcCtD
Methimazole—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000782	0.00517	CcSEcCtD
Methimazole—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000781	0.00517	CcSEcCtD
Methimazole—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000775	0.00513	CcSEcCtD
Methimazole—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000775	0.00513	CcSEcCtD
Methimazole—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.000769	0.00509	CcSEcCtD
Methimazole—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000765	0.00507	CcSEcCtD
Methimazole—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000762	0.00505	CcSEcCtD
Methimazole—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000751	0.00497	CcSEcCtD
Methimazole—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00072	0.00477	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.00471	CcSEcCtD
Methimazole—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000708	0.00469	CcSEcCtD
Methimazole—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000707	0.00468	CcSEcCtD
Methimazole—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000706	0.00467	CcSEcCtD
Methimazole—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000705	0.00467	CcSEcCtD
Methimazole—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000705	0.00467	CcSEcCtD
Methimazole—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000702	0.00465	CcSEcCtD
Methimazole—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.0007	0.00463	CcSEcCtD
Methimazole—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.0007	0.00463	CcSEcCtD
Methimazole—Lymphadenopathy—Epirubicin—peripheral nervous system neoplasm	0.000697	0.00461	CcSEcCtD
Methimazole—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000696	0.00461	CcSEcCtD
Methimazole—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000696	0.00461	CcSEcCtD
Methimazole—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000696	0.00461	CcSEcCtD
Methimazole—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000696	0.00461	CcSEcCtD
Methimazole—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000691	0.00457	CcSEcCtD
Methimazole—TPO—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.000689	0.255	CbGpPWpGaD
Methimazole—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000671	0.00444	CcSEcCtD
Methimazole—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000668	0.00442	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000656	0.00434	CcSEcCtD
Methimazole—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00433	CcSEcCtD
Methimazole—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000648	0.00429	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.000645	0.00427	CcSEcCtD
Methimazole—Oedema—Vincristine—peripheral nervous system neoplasm	0.000643	0.00426	CcSEcCtD
Methimazole—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00063	0.00417	CcSEcCtD
Methimazole—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000628	0.00416	CcSEcCtD
Methimazole—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000624	0.00413	CcSEcCtD
Methimazole—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000623	0.00413	CcSEcCtD
Methimazole—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000623	0.00413	CcSEcCtD
Methimazole—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000615	0.00407	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000608	0.00403	CcSEcCtD
Methimazole—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000599	0.00397	CcSEcCtD
Methimazole—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000593	0.00393	CcSEcCtD
Methimazole—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000593	0.00393	CcSEcCtD
Methimazole—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000588	0.00389	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000586	0.00388	CcSEcCtD
Methimazole—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000578	0.00382	CcSEcCtD
Methimazole—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000574	0.0038	CcSEcCtD
Methimazole—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000572	0.00378	CcSEcCtD
Methimazole—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000569	0.00377	CcSEcCtD
Methimazole—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000569	0.00377	CcSEcCtD
Methimazole—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000565	0.00374	CcSEcCtD
Methimazole—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00056	0.00371	CcSEcCtD
Methimazole—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00056	0.00371	CcSEcCtD
Methimazole—Rash—Topotecan—peripheral nervous system neoplasm	0.00056	0.00371	CcSEcCtD
Methimazole—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000559	0.0037	CcSEcCtD
Methimazole—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000557	0.00369	CcSEcCtD
Methimazole—Headache—Topotecan—peripheral nervous system neoplasm	0.000556	0.00368	CcSEcCtD
Methimazole—Rash—Tretinoin—peripheral nervous system neoplasm	0.000555	0.00368	CcSEcCtD
Methimazole—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000555	0.00368	CcSEcCtD
Methimazole—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000555	0.00367	CcSEcCtD
Methimazole—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000555	0.00367	CcSEcCtD
Methimazole—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000553	0.00366	CcSEcCtD
Methimazole—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000552	0.00365	CcSEcCtD
Methimazole—Headache—Tretinoin—peripheral nervous system neoplasm	0.000552	0.00365	CcSEcCtD
Methimazole—Rash—Melphalan—peripheral nervous system neoplasm	0.000548	0.00363	CcSEcCtD
Methimazole—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000548	0.00363	CcSEcCtD
Methimazole—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00053	0.00351	CcSEcCtD
Methimazole—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000528	0.00349	CcSEcCtD
Methimazole—Nausea—Topotecan—peripheral nervous system neoplasm	0.000527	0.00349	CcSEcCtD
Methimazole—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000523	0.00346	CcSEcCtD
Methimazole—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000523	0.00346	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000518	0.00343	CcSEcCtD
Methimazole—Nausea—Melphalan—peripheral nervous system neoplasm	0.000516	0.00342	CcSEcCtD
Methimazole—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000511	0.00338	CcSEcCtD
Methimazole—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00051	0.00338	CcSEcCtD
Methimazole—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000509	0.00337	CcSEcCtD
Methimazole—TPO—Differentiation Pathway—ALK—peripheral nervous system neoplasm	0.000476	0.176	CbGpPWpGaD
Methimazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000472	0.00313	CcSEcCtD
Methimazole—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000468	0.0031	CcSEcCtD
Methimazole—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000463	0.00307	CcSEcCtD
Methimazole—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000458	0.00303	CcSEcCtD
Methimazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000458	0.00303	CcSEcCtD
Methimazole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000454	0.00301	CcSEcCtD
Methimazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00045	0.00298	CcSEcCtD
Methimazole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000449	0.00297	CcSEcCtD
Methimazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000446	0.00296	CcSEcCtD
Methimazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000428	0.00283	CcSEcCtD
Methimazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000427	0.00283	CcSEcCtD
Methimazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.00281	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.00281	CcSEcCtD
Methimazole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000421	0.00279	CcSEcCtD
Methimazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000421	0.00278	CcSEcCtD
Methimazole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000418	0.00277	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.00275	CcSEcCtD
Methimazole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000414	0.00274	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.00273	CcSEcCtD
Methimazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000412	0.00273	CcSEcCtD
Methimazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000411	0.00272	CcSEcCtD
Methimazole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000409	0.00271	CcSEcCtD
Methimazole—Rash—Vincristine—peripheral nervous system neoplasm	0.000406	0.00268	CcSEcCtD
Methimazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000405	0.00268	CcSEcCtD
Methimazole—Headache—Vincristine—peripheral nervous system neoplasm	0.000403	0.00267	CcSEcCtD
Methimazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.00262	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.00262	CcSEcCtD
Methimazole—Nausea—Vincristine—peripheral nervous system neoplasm	0.000382	0.00253	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.00252	CcSEcCtD
Methimazole—TPO—Amine-derived hormones—TH—peripheral nervous system neoplasm	0.000378	0.14	CbGpPWpGaD
Methimazole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000369	0.00244	CcSEcCtD
Methimazole—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000363	0.00241	CcSEcCtD
Methimazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000362	0.00239	CcSEcCtD
Methimazole—Rash—Cisplatin—peripheral nervous system neoplasm	0.000359	0.00237	CcSEcCtD
Methimazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000358	0.00237	CcSEcCtD
Methimazole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000338	0.00224	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.00223	CcSEcCtD
Methimazole—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000331	0.00219	CcSEcCtD
Methimazole—Rash—Etoposide—peripheral nervous system neoplasm	0.000329	0.00218	CcSEcCtD
Methimazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000328	0.00217	CcSEcCtD
Methimazole—Headache—Etoposide—peripheral nervous system neoplasm	0.000326	0.00216	CcSEcCtD
Methimazole—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00213	CcSEcCtD
Methimazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00212	CcSEcCtD
Methimazole—Nausea—Etoposide—peripheral nervous system neoplasm	0.00031	0.00205	CcSEcCtD
Methimazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00202	CcSEcCtD
Methimazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00202	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00197	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.00196	CcSEcCtD
Methimazole—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00193	CcSEcCtD
Methimazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000286	0.00189	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.00187	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.00187	CcSEcCtD
Methimazole—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00179	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000266	0.00176	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00175	CcSEcCtD
Methimazole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00174	CcSEcCtD
Methimazole—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00172	CcSEcCtD
Methimazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000257	0.0017	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.00163	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.00161	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00159	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.00157	CcSEcCtD
Methimazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00154	CcSEcCtD
Methimazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000231	0.00153	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00142	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.00141	CcSEcCtD
Methimazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000207	0.00137	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00127	CcSEcCtD
Methimazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00123	CcSEcCtD
Methimazole—Rash—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00122	CcSEcCtD
Methimazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00122	CcSEcCtD
Methimazole—Headache—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00121	CcSEcCtD
Methimazole—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00115	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00114	CcSEcCtD
Methimazole—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00113	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00113	CcSEcCtD
Methimazole—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00112	CcSEcCtD
Methimazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00106	CcSEcCtD
Methimazole—TPO—Differentiation Pathway—HGF—peripheral nervous system neoplasm	0.000122	0.0451	CbGpPWpGaD
Methimazole—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	7.18e-05	0.0265	CbGpPWpGaD
Methimazole—TPO—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	5.27e-05	0.0195	CbGpPWpGaD
Methimazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	4.69e-05	0.0173	CbGpPWpGaD
Methimazole—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.22e-05	0.0156	CbGpPWpGaD
Methimazole—TPO—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.12e-05	0.0152	CbGpPWpGaD
Methimazole—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	3.98e-05	0.0147	CbGpPWpGaD
Methimazole—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	3.41e-05	0.0126	CbGpPWpGaD
Methimazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.24e-05	0.012	CbGpPWpGaD
Methimazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.18e-05	0.0117	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	2.83e-05	0.0104	CbGpPWpGaD
Methimazole—TPO—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.78e-05	0.0103	CbGpPWpGaD
Methimazole—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.57e-05	0.00951	CbGpPWpGaD
Methimazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	2.57e-05	0.00949	CbGpPWpGaD
Methimazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.35e-05	0.00867	CbGpPWpGaD
Methimazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.24e-05	0.00826	CbGpPWpGaD
Methimazole—TPO—Metabolism—GNS—peripheral nervous system neoplasm	2.01e-05	0.00743	CbGpPWpGaD
Methimazole—TPO—Metabolism—NME1—peripheral nervous system neoplasm	1.93e-05	0.00712	CbGpPWpGaD
Methimazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	1.91e-05	0.00706	CbGpPWpGaD
Methimazole—TPO—Metabolism—COX2—peripheral nervous system neoplasm	1.85e-05	0.00686	CbGpPWpGaD
Methimazole—CYP2A6—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	1.59e-05	0.00587	CbGpPWpGaD
Methimazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	1.55e-05	0.00572	CbGpPWpGaD
Methimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	1.47e-05	0.00545	CbGpPWpGaD
Methimazole—CYP2A6—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	1.34e-05	0.00496	CbGpPWpGaD
Methimazole—TPO—Metabolism—ENO2—peripheral nervous system neoplasm	1.22e-05	0.0045	CbGpPWpGaD
Methimazole—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	1.22e-05	0.0045	CbGpPWpGaD
Methimazole—TPO—Metabolism—BCHE—peripheral nervous system neoplasm	1.03e-05	0.0038	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.98e-06	0.00369	CbGpPWpGaD
Methimazole—TPO—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.82e-06	0.00363	CbGpPWpGaD
Methimazole—TPO—Metabolism—TH—peripheral nervous system neoplasm	9.67e-06	0.00358	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	9.23e-06	0.00341	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	8.42e-06	0.00311	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.06e-06	0.00298	CbGpPWpGaD
Methimazole—TPO—Metabolism—GNAS—peripheral nervous system neoplasm	7.9e-06	0.00292	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.89e-06	0.00292	CbGpPWpGaD
Methimazole—TPO—Metabolism—ABCB1—peripheral nervous system neoplasm	7.75e-06	0.00286	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	7.19e-06	0.00266	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.74e-06	0.00249	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	6.39e-06	0.00236	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.09e-06	0.00225	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	5.95e-06	0.0022	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.6e-06	0.00207	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.55e-06	0.00205	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.44e-06	0.00201	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.33e-06	0.00197	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	4.88e-06	0.0018	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.74e-06	0.00175	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	4.67e-06	0.00173	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	4.67e-06	0.00173	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	4.5e-06	0.00166	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.11e-06	0.00152	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	3.93e-06	0.00145	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	3.85e-06	0.00142	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.78e-06	0.0014	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	3.77e-06	0.00139	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.75e-06	0.00139	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	3.69e-06	0.00137	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.66e-06	0.00135	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	3.63e-06	0.00134	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	3.56e-06	0.00131	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.42e-06	0.00126	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.2e-06	0.00118	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.12e-06	0.00115	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	2.97e-06	0.0011	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	2.95e-06	0.00109	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	2.85e-06	0.00105	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	2.74e-06	0.00101	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	2.73e-06	0.00101	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	2.71e-06	0.001	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.66e-06	0.000984	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	2.62e-06	0.000969	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	2.6e-06	0.000961	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	2.52e-06	0.000933	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	2.5e-06	0.000925	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	2.5e-06	0.000923	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.47e-06	0.000914	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	2.38e-06	0.000881	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.38e-06	0.00088	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	2.35e-06	0.000868	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	2.33e-06	0.000863	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	2.32e-06	0.000856	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.22e-06	0.000821	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.14e-06	0.00079	CbGpPWpGaD
Methimazole—TPO—Metabolism—AKT1—peripheral nervous system neoplasm	2.13e-06	0.000788	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	2.01e-06	0.000744	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	1.97e-06	0.000729	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.92e-06	0.00071	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	1.92e-06	0.000708	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.89e-06	0.0007	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.88e-06	0.000696	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.88e-06	0.000695	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	1.85e-06	0.000686	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	1.8e-06	0.000666	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.79e-06	0.000661	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.71e-06	0.000634	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.66e-06	0.000612	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.65e-06	0.00061	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.64e-06	0.000607	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.55e-06	0.000571	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	1.52e-06	0.000563	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.52e-06	0.000561	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	1.51e-06	0.00056	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.49e-06	0.000549	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.45e-06	0.000537	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	1.43e-06	0.000529	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.4e-06	0.000519	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.4e-06	0.000517	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.39e-06	0.000513	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.34e-06	0.000494	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.32e-06	0.000489	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.32e-06	0.000486	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.3e-06	0.000482	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.19e-06	0.000438	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.17e-06	0.000432	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.15e-06	0.000424	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.13e-06	0.000418	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.11e-06	0.000412	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.08e-06	0.0004	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.07e-06	0.000397	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.07e-06	0.000394	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.05e-06	0.00039	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.05e-06	0.000386	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	9.15e-07	0.000338	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	9.1e-07	0.000336	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	8.93e-07	0.00033	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.73e-07	0.000323	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	8.6e-07	0.000318	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	7.02e-07	0.00026	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	6.89e-07	0.000255	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	5.17e-07	0.000191	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	4.17e-07	0.000154	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	4.09e-07	0.000151	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	3.15e-07	0.000117	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.9e-07	0.000107	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.87e-07	0.000106	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.46e-07	9.08e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.9e-07	7.01e-05	CbGpPWpGaD
